Simplify Asset Management Inc.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1846368 Las Vegas, NV

Position in VRTX

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$3,543,741

-$4,386,432 QoQ

Shares Held

7,936

-54.6% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

1.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Simplify Asset Management Inc. holds $73,409,607 across 36 Biotechnology names. VRTX ranks #6 (4.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	51,730	$9,779,556
2	REGN	Regeneron Pharmaceuticals, Inc.	10,900	$8,421,776
3	BHVN	Biohaven Ltd.	898,400	$7,600,464
4	BNTC	Benitec Biopharma Inc.	562,242	$5,987,877
5	EYPT	EyePoint, Inc.	326,142	$4,203,970
6	VRTX	Vertex Pharmaceuticals Inc / Ma This page	7,936	$3,543,741
7	ACHV	Achieve Life Sciences, Inc.	1,184,512	$3,482,465
8	PHAT	Phathom Pharmaceuticals, Inc.	262,386	$2,915,108

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,543,741	7,936	-54.6%	Shares	Sole	2026-04-27
2025-12-31	$7,930,173	17,492	+1327.9%	Shares	Sole	2026-02-09
2025-09-30	$479,759	1,225	+13.3%	Shares	Sole	2025-10-20
2025-06-30	$481,261	1,081	-9.5%	Shares	Sole	2025-08-07
2025-03-31	$579,359	1,195	-74.5%	Shares	Sole	2025-05-13
2024-12-31	$1,888,260	4,689	+102.9%	Shares	Sole	2025-02-11
2023-12-31	$940,322	2,311	-68.9%	Shares	Sole	2024-02-12
2023-09-30	$2,581,969	7,425	-0.9%	Shares	Sole	2023-11-14
2023-06-30	$2,636,157	7,491	+973.2%	Shares	Sole	2023-08-14
2022-12-31	$201,568	698	—	Shares	Sole	2023-02-10
No filing history on record for this holder in this stock.